The handbook on Responsible Partnering provides guidelines aiming at improving strategic collaboration and knowledge exchange between companies and publicly-funded research organizations.
The path from understanding a disease to bringing a safe and effective new treatment to patients is lengthy and complex. Scientists work to piece together the basic causes of disease at the level of genes, proteins and cells.
This White Paper summarizes the reflections and discussions during the meetings of the Advisory Board of the EU FP7 project Entente (HEALTH-F1- 2012-305128 )
“You don’t have to make all the mistakes yourself” - this September’s raft of ASTP-Proton training courses are lining up to make a real impact on the professional development and network community of the participants.
The TTO of Polytechnic of Milan is one of the first technology transfer offices established in Italy and is among the founding members of the Netval (TTO Network of the Italian universities).
The development of life science technologies typically involve long timelines and stringent regulatory hurdles, which in combination result in a high investment capital need. In contrast, the financial and societal reward can be tremendous in case of success.
This UNICO Practical Guide covers a selection of topics that are relevant to the management of technology transfer (TT) agreements and relationships.
While the IP Office recognizes that the specifics of any start-up company development may be unique, it has identified a number of common elements and the IP Office has developed standard mechanisms and support structures to assist with this process.
This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
Founded in 2001 as a wholly-owned subsidiary of the LifeScience Foundation, Ascenion is a technology transfer company focusing on the field of life sciences. It currently serves a total of 23 research institutes and university hospitals all over Germany.
The IOCB Technology Transfer Office s.r.o (IOCB TTO) is a wholly-owned subsidiary company of IOCB and a leading technology transfer office in the Czech Republic in the field of pharmaceutical, chemical and biotechnology research and development.
Join our newsletter and get the latest news